Kevin Charles Gorman, Director at NEUROCRINE BIOSCIENCES INC (NBIX), sold 212,644 shares at $126.41 ($26.9M) on 2025-08-07, disclosed to the SEC on 2025-08-11.
Scheduled sale ($26.9M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $126.41 | 106,322 | $13.4M | 50.0% |
| 2 | $126.41 | 106,322 | $13.4M | 50.0% |
| Total | $126.41 avg | 212,644 | $26.9M | 100% |
| Filing → |
| XNCR | SELL | 2025-06-16 | $29K | — | Filing → |
| NBIX | SELL | 2025-05-29 | $2.3M | — | Filing → |
| NBIX | SELL | 2025-02-14 | $1.4M | — | Filing → |